Replimune Group
REPL
106 hedge funds and large institutions have $704M invested in Replimune Group in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 48 increasing their positions, 26 reducing their positions, and 8 closing their positions.
85% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 26
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
4% more funds holding
Funds holding: 102 → 106 (+4)
1.15% more ownership
Funds ownership: 81.52% → 82.66% (+1.1%)
1% more capital invested
Capital invested by funds: $696M → $704M (+$7.51M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$8.43M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$7.44M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$5.77M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$4.13M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$32.6M |
| 2 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$7.35M |
| 3 |
State Street
Boston,
Massachusetts
|
-$3.81M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.25M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.99M |
REPL Hedge Fund Activity: Q3 2022 in Review
106 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q3 2022, worth a combined $704M — up 1.1% from $696M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new REPL positions and 8 closed out — a net gain of 4 holders — while 48 added to existing stakes and 26 trimmed.
The largest buyer was BlackRock, adding an estimated $8.43M. The largest seller was T. Rowe Price Associates, cutting an estimated $32.6M.
- 106 institutional investors held Replimune Group (REPL) as of Q3 2022, up from 102 in Q2 2022.
- Funds reported $704M of Replimune Group stock for Q3 2022, up 1.1% quarter-over-quarter.
- 12 funds opened new Replimune Group positions in Q3 2022 and 8 closed out, a net change of +4 holders.
- The largest Replimune Group buyer in Q3 2022 was BlackRock, an estimated $8.43M added.
- The largest Replimune Group seller in Q3 2022 was T. Rowe Price Associates, an estimated $32.6M sold.
Based on aggregated 13F filings for Q3 2022.